Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 20, 2021 - Issue 4
Submit an article Journal homepage
2,031
Views
4
CrossRef citations to date
0
Altmetric
Editorial

Bosutinib – related pleural effusion in patients with chronic myeloid leukemia

Mebrure Burçak Yüzbaşıoğlua Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, TurkeyView further author information
&
Ahmet Emre Eşkazanb Division of Hematology, Department of Internal Medicine, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, TurkeyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0001-9568-0894View further author information
ORCID Icon
Pages 379-381 | Received 14 Oct 2020, Accepted 17 Dec 2020, Published online: 08 Jan 2021

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Necati Alp Kılıçaslan, Şermin Börekçi, Gül Nihal Özdemir, Müge Sayitoğlu & Ahmet Emre Eşkazan. (2022) Dasatinib-related pleural effusion and lymphocytosis rates are different between adult and pediatric patients with Philadelphia chromosome-positive leukemias: are age and comorbidities only to blame?. Expert Review of Respiratory Medicine 16:8, pages 849-852.
Read now

Articles from other publishers (3)

Jing Huang, Juanjuan Cai, Qingqing Ye, Qiaoying Jiang, Huan Lin & Lun Wu. (2023) Fluid retention-associated adverse events in patients treated with BCR::ABL1 inhibitors based on FDA Adverse Event Reporting System (FAERS): a retrospective pharmacovigilance study. BMJ Open 13:8, pages e071456.
Crossref
I. Farinha, J. Gaião Santos, A. Cunha & T. Costa. (2022) Chylothorax as an unusual presentation of Bosutinib therapy toxicity. Pulmonology.
Crossref
Wenjuan Yu, Xin Du, Weiguang Wang, Jin Lou, Peng Liu, Li Meng & Jie Jin. (2022) Efficacy and Safety of Generic Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Multicenter Prospective Study in China. Clinical Lymphoma Myeloma and Leukemia 22:9, pages e867-e873.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.